In Brief This Week: Roche, Genome Institute of Singapore; Bruker Daltonics; Genomic Health; RainDance Technologies; and More | GenomeWeb Daily News | GenomeWeb: "NEW YORK (GenomeWeb News) – Roche said this week that researchers at the Genome Institute of Singapore have developed a PCR-based approach that is used with the firm's NimbleGen arrays for sequencing the entire genome of any influenza A virus in around 24 hours. According to Roche, the method will enable faster development of diagnostics for any possible new variant and rapidly determine if a strain of DNA has become drug resistant.
The firm said that Nimblegen arrays were used during the SARS outbreak in 2003 to understand the infectious source and globally monitor the SARS virus.
Roche also said this week that its Roche Applied Science business has opened a new application support center in Shanghai, China."
Affymetric moves the majority of its probe array manufacturing to its Singapore operations.
Another great loss for America.
No comments:
Post a Comment